{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:16:08Z","timestamp":1760832968451,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.bmcl.2011.07.061","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T17:07:42Z","timestamp":1312218462000},"page":"5957-5960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists"],"prefix":"10.1016","volume":"21","author":[{"given":"Dahui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Y.","family":"Sze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adedayo B.","family":"Adedoyin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bowlby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Comery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert J.","family":"Robichaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2011.07.061_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd1631","volume":"4","author":"Leurs","year":"2005","journal-title":"Drug Disc."},{"key":"10.1016\/j.bmcl.2011.07.061_b0010","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bcp.2005.10.033","volume":"71","author":"Hancock","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bmcl.2011.07.061_b0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"Fox","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bmcl.2011.07.061_b0020","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.107.120311","volume":"321","author":"Medhurst","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bmcl.2011.07.061_b0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/156802610790411027","volume":"10","author":"Raddatz","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bmcl.2011.07.061_b0030","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bmcl.2009.11.122","volume":"20","author":"Cole","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2011.07.061_b0035","unstructured":"Gross, J. Gordon Research Conferences, Medicinal Chemistry August 3-8, 2008, Colby-Sawyer College, New London, NH."},{"key":"10.1016\/j.bmcl.2011.07.061_b0040","unstructured":"Williams, M. J.; Gross, J. L.; Adedoyin, A.; Aschmies, S.; Brennan, J.; Day, M.; Di, L.; Golembieski, J.; Grauer, S.; Hirst, W. D.; Kelley, C.; Kim, J.; Kubek, K.; Marquis, K.; Navarra, R.; Pausch, M.; Solvibile, W. R.; Zhang, G.; Brandon, N.; Comery, T.; Robichaud, A. J. 237th ACS National Meeting, Salt Lake City, UT, United States, March 22-26, 2009, MEDI-259."},{"issue":"6","key":"10.1016\/j.bmcl.2011.07.061_b0045","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1021\/jm049212n","volume":"48","author":"Dvorak","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2011.07.061_b0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijpharm.2006.03.007","volume":"317","author":"Di","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bmcl.2011.07.061_b0055","unstructured":"hERG channel screening: hERG data was obtained from Essen Instruments Inc. (1156 Oak Valley Drive, Ann Arbor, Michigan 48108 USA, ics@essen-instruments.com) on an Ionworks\u2122 Quattro platform."},{"issue":"2","key":"10.1016\/j.bmcl.2011.07.061_b0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","volume":"288","author":"Wang","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bmcl.2011.07.061_b0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/327117a0","volume":"327","author":"Arrang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2011.07.061_b0070","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1517\/13543776.13.6.851","volume":"13","author":"Stark","year":"2003","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bmcl.2011.07.061_b0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0031-9384(95)02048-9","volume":"58","author":"Kraly","year":"1995","journal-title":"Physiol. Behav."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X11010079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X11010079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:26:52Z","timestamp":1760768812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X11010079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":15,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0960894X11010079"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2011.07.061","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2011.07.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}